Key facts
- Xingshun New Material’s last known valuation is $63.0M (Mar 2022).
- It has raised $15.7M; the latest was Later Stage VC in Dec 2024.
- Notable investors include Dongguan Born Good Capital Investment, Jundu Investment, Pine Venture Capital, Ruixing Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Xingshun New Material
- ·The full record, as it builds
Funding rounds
No funding rounds for Xingshun New Material are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Xingshun New Material
Developer of fine chemicals and pharmaceutical intermediates designed for the chemical industry. The company mainly focuses on the research and development of fine chemicals and pharmaceutical intermediates, which are empowered by large-scale experimental bases and various chemical experimental equipment, providing customers with cost-effective products and services.
- Sector
- Materials and Resources
- HQ
- Heze, China
- Founded
- 1996
- Employees
- 120
- Website
- sd-xingshun.com/
- Ownership
- Privately Held (backing)
Xingshun New Material doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Xingshun New Material shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Xingshun New Material in its N-PORT filings yet. We sweep new filings monthly.